Article
Tacrolimus trough concentrations increase during antibiotherapy despite stable dosing in kidney transplant recipients – a retrospective analysis
2026-08-10
Abstract excerpt
<b>Aim/</b> Kidney transplant recipients (KTR) require lifelong immunosuppression with tacrolimus (TAC), a narrow therapeutic index drug with high intra- and inter-patient pharmacokinetic (PK) variability. Evidence suggests the gut microbiome modulates TAC dose requirements. Given the frequent use of antibiotics in KTR, this study investigates their impact on TAC PK to clarify the microbiome’s role in TAC PK varia...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fb39ba65-d4ef-538c-8b44-cd4957c4ea20
- DOI
- 10.22541/authorea.15007233/v1
